Dr Michael Krasovitsky
FRACP, MBBS (Hons), MIPH (Dist), BA (Langs) (Hons), DCH
For patients/carers
For doctors
FRACP, MBBS (Hons), MIPH (Dist), BA (Langs) (Hons), DCH
Locations
Clinical interests
- Breast cancer
- Lung cancer
- Liver cancer
- Oncology geriatrics
- Mesothelioma
- Thyroid cancer
Treatment techniques
- Medical oncology
- Chemotherapy
- Targeted therapy
- Hormone therapy
- Immunotherapy
Languages
Fluent
- English
- French / Français
Conversational
- Spanish Español
Biography
Medical Oncologist with clinical interests in breast, lung and liver cancers, as well as managing cancers in older individuals
Dr Krasovitsky is a medical oncologist specialising in the treatment of lung, breast and liver cancers. He has particular expertise in older age oncology but treats individuals of all ages.
Dr Krasovitsky is also a senior academic lecturer at the University of New South Wales, where he is actively involved in research and teaching. He chairs several national organisations focused on optimising cancer treatment for older individuals.
More information
Dr Krasovitsky has specialist training in thoracic, breast and liver cancers. He is also a specialist geriatric oncologist with experience in the supportive and palliative care of individuals with cancer.
- Chair, Geriatric Oncology Group, Clinical Oncology Society of Australia (COSA)
- Chair, Geriatric Oncology Emerging Experts and Researchers Group, Clinical Oncology Society of Australia (COSA)
- Medical Oncology Group of Australia (MOGA)
- Thoracic Oncology Group of Australia (TOGA)
- International Association for the Study of Lung Cancer (IASLC)
- Breast Cancer Trials (BCT)
- International Liver Cancer Association (ILCA)
- McNamee, N., McCloy, R. A., Brown, B. B., Krasovitsky, M., Joshua, A., Boyer, M., Simes, J., & Chin, V. (2026). GDF15 biomarker performance in older patients with advanced non-small cell lung cancer. Journal of Geriatric Oncology, 17(6), 103028. doi: 10.1016/j.jgo.2026.103028
- Yuile, A., Satgunaseelan, L., Alexander, K. L., Thavaneswaran, S., Sim, H.-W., Krasovitsky, M., Kong, B. Y., Miller, S., Buckland, M. E., Lee, M., Wei, G., Kastelan, M., Wong, M., Wilson, I., Bayly, A., Varikatt, W., Lwin, Z., Turner, C., Back, M. F., ... Lee, A. (2025). Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas: A cohort study and patterns of care survey. Neuro-Oncology Practice, 12(5), 787–796. doi: 10.1093/nop/npaf045
- Zheng, M.-D., Li, Y.-X., Wang, Z.-Y., Ma, H., Wang, Y., Qiao, T.-T., Krasovitsky, M. S., Tatar, C., Karlekar, M., & Yan, J. (2024). Patient-controlled analgesia with hydromorphone treatment for advanced colon cancer with severe pain in an older adult patient: A case report and literature review. Journal of Gastrointestinal Oncology, 15(5), 2330–2337. doi: 10.21037/jgo-24-713
- Ungar, A., Cherubini, A., Fratiglioni, L., de la Fuente-Núñez, V., Fried, L. P., Krasovitsky, M. S., Tinetti, M., Officer, A., Vellas, B., & Ferrucci, L. (2024). Carta of Florence against ageism: No place for ageism in healthcare. Innovation in Aging, 8(2), igad133. doi: 10.1093/geroni/igad133
- Krasovitsky, M., Lee, Y. C., Sim, H.-W., Chawla, T., Moore, H., Moses, D., Baker, L., Mandel, C., Kielar, A., Hartery, A., O'Malley, M., Friedlander, M., Oza, A. M., Wang, L., Lheureux, S., & Wilson, M. (2022). Interobserver and intraobserver variability of RECIST assessment in ovarian cancer. International Journal of Gynecological Cancer, 32(5), 656–661. doi: 10.1136/ijgc-2021-003319
Explore more
You are leaving our website
You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.